Stimulant use disorder clinical trials
24 active trials name this condition. Describe your situation to see which ones you may be eligible for.
By location
- reSET for the Treatment of Stimulant Use in HIV Clinics: Care Optimization Supporting Treatment Adherence (COSTA)
- Psilocybin for Methamphetamine Addiction
- RESTORE Study R61 Phase: Recovery and Engagement for Stimulant Users on Re-entry
- Smartphone Services for Stimulant Use Disorder
- Orexin Receptor Antagonism and Sleep in Stimulant Use Disorder
- Neuromodulation and Cognitive Training for Substance Use Disorders
- Accelerated rTMS for Substance Use Disorder and Depression
- Optimizing Transcranial Magnetic Stimulation for Stimulant Use Disorder
- Continuum of Care in Hospitalized Patients With Opioid/Stimulant Use Disorder and Infectious Complications From Drug Use
- Project neuroARTEMIS
- Naltrexone for Overdose Prevention
- Kentucky Women's Justice Community Overdose Innovation Network - Phase II
- Optimizing Pregnancy and Treatment Interventions for Moms 3.0
- Leveraging mHealth to Promote Opioid Use Recovery and Mental Health Among Residents of a Medium-Sized Midwestern City
- The ENHANCE Project Toolkit
- Repetitive Transcranial Magnetic Stimulation Treatment of Stimulant Use Disorder
- Emotional Brain Training for Addiction Medicine Treatment - A Pilot Study
- Culturally Adapted Contingency Management
- Remote Fentanyl Test Strip Distribution and Education to Prevent Drug Overdose
- The Community Paramedic Response and Overdose Outreach With Supportive Medical-Legal Services Study
- LDART for Stimulant Use Disorder
- An Open-Label Tirzepatide Trial for Comorbid Obesity and Stimulant Use Disorder
- Developing and Testing Innovative Care Pathways for Screening and Treatment of OUD/PTSD in Jails
- Enhancing Prospective Thinking in Early Recovery
Guides for people searching for a trial
- Why people get turned down — and what to do nextWhat eligibility criteria are for, what keeps people out, and where to go when the first door closes.
- How your biomarkers decide which trials you qualify forEGFR, HER2, BRAF, PD-L1 and the rest — what they are and why they increasingly gate access.
- How to search for a trial without losing your mindWhere to look, what to gather first, and how to read what you find.
- What Phase 1, 2 and 3 actually mean for youWhat each phase is testing, and how to weigh an early-phase trial against a later one.
- 10 questions to ask before you say yesTreatment, time, cost, safety and your rights. Worth bringing to a screening visit.
- You matched with a trial. What happens now?Phone screens, the screening visit, informed consent, and day one.
Showing active trials that list “Stimulant use disorder” as a condition. Eligibility shown on each trial is an estimate — the trial's study team makes the final decision.